
A new study has indicated that combination of drugs inhibiting receptor tyrosine kinases (RTKs)and targeting inhibitors of apoptosis (IAP) may improve cancer therapy efficacy.
Previous studies have shown that therapeutics targeting RTKs would likely be beneficial to individuals with glioblastoma multiforme (GBM), one of the most aggressive types of brain tumour.
Advertisement
However, a small proportion of patients respond to such treatment and most subsequently relapse after only a short time.
During the study, human GBM cells were exposed in vitro to an inhibitor of the RTK PDGFR, which in turn activated a cellular pathway that usually induces cells to undergo a form of cell death known as apoptosis, but the final steps of the pathway were not completed, meaning that the cells did not die.
The team found that final steps of this pathway were blocked by a group of proteins known as IAPs.
The study suggested that if the PDGFR inhibitor was combined with an IAP inhibitor the GBM cells underwent apoptosis.
Further, this drug combination showed enhanced efficacy at stalling tumour growth in an orthotopic mouse model of GBM.
The authors revealed that combining drugs targeting IAPs with RTK inhibitors might prove beneficial to individuals with GBM.
Source: ANI
RAS/L
Advertisement
The team found that final steps of this pathway were blocked by a group of proteins known as IAPs.
The study suggested that if the PDGFR inhibitor was combined with an IAP inhibitor the GBM cells underwent apoptosis.
Further, this drug combination showed enhanced efficacy at stalling tumour growth in an orthotopic mouse model of GBM.
The authors revealed that combining drugs targeting IAPs with RTK inhibitors might prove beneficial to individuals with GBM.
Source: ANI
RAS/L
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News

The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.

The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.

Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.

Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.

In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.